Issue Date: September 17, 2012
Cambridge Major Expands Capacity
Cambridge Major Laboratories has expanded its large-scale active pharmaceutical ingredient facility in Germantown, Wis. The custom manufacturer is among a group of firms that has been investing in U.S. assets, particularly in the Midwest. “Our faith in the ‘invest in the West’ policy initiated a few years ago continues to bear fruit,” CEO Brian Scanlan says. The company says it added reactor capacity and isolation equipment to support increasing demand for commercial and late-stage development products. It plans to add product-containment capabilities at its Weert, the Netherlands, facility later this year.
- Chemical & Engineering News
- ISSN 0009-2347
- Copyright © American Chemical Society